NCT06431347 Prospective Observational Cohort Study of Transplant and Cell Therapy Candidates and Recipients to Assess Social Determinants of Health
| NCT ID | NCT06431347 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Transplant and Cell Therapy |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-06-17 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-06-17 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To learn more about social and financial factors that may influence outcomes of TCT treatment at MD Anderson.
Eligibility Criteria
Inclusion Criteria 1. ≥ 18 years of age. 2. Received financial clearance for TCT. Qualitative study - patients 1. Patient ≥ 18 years of age who is currently cared for at MD Anderson as a TCT candidate/ recipient, 2. The patient reports social and/or financial challenges impacting care delivery. 3. The patient is willing to participate in a semi-structured interview. Qualitative study - caregivers 1. Caregiver(s) of a patient ≥ 18 years of age who is currently cared for at MD Anderson as a TCT candidate/ recipient. 2. The patient reports social and/or financial challenges impacting care delivery. 3. The patient has referred the caregiver(s) to participate and provided us with permission to contact their caregiver(s). 4. The caregiver(s) is (are) willing to participate in a semi-structured interview. Exclusion Criteria Patients - Quantitative study 1) Did not receive financial clearance for TCT Patients - Qualitative study 1\) Not impacted by social or financial challenges. Caregivers (qualitative study) 1. Did not care for a patient impacted by social or financial challenges 2. Were not referred to participate in the study by patient they cared for.
Contact & Investigator
Warren Fingrut, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06431347 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Transplant and Cell Therapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06431347 currently recruiting?
Yes, NCT06431347 is actively recruiting participants. Contact the research team at wbfingrut@mdanderson.org for enrollment information.
Where is the NCT06431347 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06431347 clinical trial?
NCT06431347 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Warren Fingrut, MD at M.D. Anderson Cancer Center. The trial plans to enroll 2,000 participants.